Clinical Trials

31 trials
RecentStart dateEnrollment
Observational × Liver Diseases × Clear all
NCT06072287 2023-10-12

LTC

King's College London

Unknown
600 enrolled
Classical hematologyOther

Psychological Well-Being, Post-Acute COVID-19 Syndrome, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Celiac Disease, Cerebrovascular Disorders, Chronic Disease, Cystic Fibrosis, Dementia, Depression, Diabetes Mellitus, Eczema, Endometriosis, Epilepsy, Fibromyalgia, Heart Diseases, Heart Failure, Hepatitis, Hypertension, Liver Diseases, Migraine Disorders, Multiple Sclerosis, Neoplasms, Nervous System Diseases, Obesity, Osteoarthritis, Osteoporosis, Pain, Parkinson Disease, Spondylitis, Fatigue Syndrome, Chronic, Hidradenitis Suppurativa, Stroke, Pulmonary Disease, Chronic Obstructive, Postural Orthostatic Tachycardia Syndrome

NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Celgene

Completed
1,149 enrolled
GenitourinaryPlasma cell

Sleepiness, Arrhythmias, Cardiac, Confusion, Consciousness Disorders, Dizziness, Fatigue, Heart Failure, Hypersensitivity, Infections, Jaundice, Liver Diseases, Multiple Myeloma, Peripheral Nervous System Diseases, Thromboembolism, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Acute Kidney Injury, Teratogenesis